We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current FTT market cap is 1.13M. The company's latest EPS is AUD -0.0107 and P/E is -2.80.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 2.53M | 689k | 0 | 0 | 0 |
| Operating Income | 1.69M | 283k | -1.11M | -916k | -804k |
| Net Income | 1.67M | 282k | -1.07M | -873k | -2.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3.13M | 3.26M | 6.89M | 5.88M | 3.62M |
| Total Liabilities | 245k | 84k | 164k | 57k | 191k |
| Total Equity | 2.89M | 3.17M | 6.72M | 5.82M | 3.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | 26k | 167k | -979k | -994k | -550k |
| Investing | N/A | N/A | -918k | -220k | -8k |
| Financing | 391k | N/A | 3.61M | -9k | N/A |
| Market Cap | 1.13M |
| Price to Earnings Ratio | -2.80 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.17 |
| Price to Book Ratio | 1.98 |
| Dividend Yield | - |
| Shares Outstanding | 225.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | -0 (-60%) |
| Company Name | Factor Therapeutics Limited |
| Address |
level 21 brisbane, queensland 4000 |
| Website | https://www.factor-therapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
